SARS-CoV-2 continued Evolution and Pathogenic Difference in Human Hosts
Mahima Sharma*
DOI : 10.46890/SL.2021.v02i02.001
Abstract
The epidemic covid 19 originated from Wuhan, China during December 2019 in and since then spread innot only in China but also throughout the world and raised a major international concern. With the continuous extensive transmission studies are evidencing for an amount of molecular differences among SARS-CoV-2 found at the originating site and other related regions globally covid 19,Genome sequencing has evidenced the presence of dissimilar strains in different regions. Severity of disease varies in countries where few regions are affected more than others virus. This evolving nature of the virus not only can affect its diagnostic methods but also manufacturing drugs or vaccine.
Download this article as: 
The epidemic covid 19 originated from Wuhan, China during December 2019 in and since then spread innot only in China but also throughout the world and raised a major international concern. With the continuous extensive transmission studies are evidencing for an amount of molecular differences among SARS-CoV-2 found at the originating site and other related regions globally covid 19,Genome sequencing has evidenced the presence of dissimilar strains in different regions. Severity of disease varies in countries where few regions are affected more than others virus. This evolving nature of the virus not only can affect its diagnostic methods but also manufacturing drugs or vaccine.